# Yulinzhu for Women With Diminished Ovarian Reserve

> **NCT07550998** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 60 (estimated)

## Conditions studied

- Diminished Ovarian Reserve (DOR)

## Interventions

- **DRUG:** Yulinzhu (a Chinese Medicinal Formulae)

## Key facts

- **NCT ID:** NCT07550998
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-24
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- Queen Mary Hospital, Hong Kong
- Kwong Wah Hospital

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07550998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07550998, "Yulinzhu for Women With Diminished Ovarian Reserve". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07550998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*